OptimizeRx Corporation
OPRX
$9.20
-$0.79-7.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.11M | -24.17M | -17.92M | -18.07M | -17.57M |
| Total Depreciation and Amortization | 4.57M | 4.25M | 3.66M | 3.08M | 2.50M |
| Total Amortization of Deferred Charges | 835.00K | 848.00K | 622.00K | 416.00K | 211.00K |
| Total Other Non-Cash Items | 18.93M | 26.13M | 21.10M | 21.82M | 23.17M |
| Change in Net Operating Assets | 671.00K | -8.61M | -9.36M | -12.28M | -15.55M |
| Cash from Operations | 4.89M | -1.57M | -1.89M | -5.04M | -7.24M |
| Capital Expenditure | -112.00K | -100.00K | -115.00K | -90.00K | -87.00K |
| Sale of Property, Plant, and Equipment | -- | 10.00K | 10.00K | 10.00K | 10.00K |
| Cash Acquisitions | -- | -82.95M | -82.95M | -82.95M | -82.95M |
| Divestitures | -- | 2.54M | 2.54M | 2.54M | 2.54M |
| Other Investing Activities | -338.00K | 54.17M | 53.26M | 56.55M | 55.15M |
| Cash from Investing | -450.00K | -26.33M | -27.25M | -23.94M | -25.34M |
| Total Debt Issued | -- | 37.73M | 37.73M | 37.73M | 37.73M |
| Total Debt Repaid | -4.00M | -3.21M | -2.71M | -2.21M | -1.71M |
| Issuance of Common Stock | -- | 15.00K | 16.00K | 121.00K | 161.00K |
| Repurchase of Common Stock | -911.00K | -733.00K | -750.00K | -7.93M | -7.96M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 300.00K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -4.91M | 34.10M | 34.29M | 27.71M | 28.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -1.00K | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -472.00K | 6.20M | 5.15M | -1.27M | -4.36M |